RecruitingPhase 2NCT02740868

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

Development of Hyperpolarized Xenon-129 and Inert Fluorinated Gas Lung Magnetic Resonance Imaging: Comparative Pilot Study of Healthy Volunteers and Participants With Pulmonary Disease


Sponsor

The Hospital for Sick Children

Enrollment

30 participants

Start Date

Aug 1, 2015

Study Type

INTERVENTIONAL

Conditions

Summary

Aim of this study is to evaluate image quality and reproducibility of Xenon-129 and Inert fluorinated (19F) gas Magnetic Resonance Imaging (MRI) and to evaluate changes in lung structure and function in participants with cystic fibrosis (CF) and asthma compared to healthy controls.


Eligibility

Min Age: 8 Years

Plain Language Summary

Simplified for easier understanding

This study is using special MRI scans with inhaled gases (xenon-129 and a fluorinated gas) to create detailed images of how air moves through the lungs, helping researchers better understand conditions like asthma, cystic fibrosis, and COPD. **You may be eligible if...** - You are 8 years or older - You have no smoking history - If you have asthma or cystic fibrosis, your symptoms are at your usual stable level - Your lung function (measured by a breathing test) is above 40% of predicted normal - You are able to hold your breath for up to 20 seconds - You can perform consistent, reproducible breathing tests **You may NOT be eligible if...** - You are a current or former smoker - Your lung function is severely reduced (below 40% of predicted) - You cannot hold your breath or cooperate with the breathing tests - You have conditions that make MRI scanning unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGXenon-129 and Perfluoropropane (19F)

Xenon gas and perfluoropropane to be inhaled by research participants

DEVICEMagnetic Resonance Imaging

Lung imaging will be performed for participants using MRI for all 3 arms

DEVICELung Clearance Index

Lung clearance index (measure of lung health) will be performed for all participants of all 3 arms


Locations(1)

The Hospital for Sick Children

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02740868


Related Trials